Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 9

Results: 30

Teva loses key MS drug patent.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4123

By:

Harrison, Charlotte

Publication type:

Article

Targeting the unfolded protein response in disease.

Published in:

2013

By:

Hetz, Claudio;
Chevet, Eric;
Harding, Heather P

Publication type:

journal article

Appropriate evidence for adaptive marketing authorization.

Published in:

2013

By:

de Jong, Jean Philippe;
Grobbee, Diederick E;
Flamion, Bruno;
Forda, Susan R;
Leufkens, Hubert G M

Publication type:

journal article

Targeting the unfolded protein response in disease.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 703, doi. 10.1038/nrd3976

By:

Hetz, Claudio;
Chevet, Eric;
Harding, Heather P.

Publication type:

Article

Improving animal research.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 653, doi. 10.1038/nrd4121
Publication type:: Article

Analgesia: Targeting the EP<sub>3</sub> receptor to combat pain.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 666, doi. 10.1038/nrd4115

By:

Charlotte, Harrison

Publication type:

Article

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 688, doi. 10.1038/nrd4099

By:

Kunkel, Gregory T.;
Maceyka, Michael;
Milstien, Sheldon;
Spiegel, Sarah

Publication type:

Article

G protein-coupled receptors: A double attack on pain.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 665, doi. 10.1038/nrd4105

By:

Harrison, Charlotte

Publication type:

Article

Regulatory evaluation of Glybera in Europe - two committees, one mission.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 719, doi. 10.1038/nrd3835-c1

By:

Melchiorri, Daniela;
Pani, Luca;
Gasparini, Paolo;
Cossu, Giulio;
Ancans, Janis;
Borg, John Joseph;
Drai, Catherine;
Fiedor, Piotr;
Flory, Egbert;
Hudson, Ian;
Leufkens, Hubert G.;
Müller-Berghaus, Jan;
Narayanan, Gopalan;
Neugebauer, Brigitte;
Pokrotnieks, Juris;
Robert, Jean-Louis;
Salmonson, Tomas;
Schneider, Christian K.

Publication type:

Article

A longer patent life for formulated drugs in Australia?

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4124

By:

Harrison, Charlotte

Publication type:

Article

Patient-focused drug development programme takes first steps.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 651, doi. 10.1038/nrd4104

By:

Mullard, Asher

Publication type:

Article

Regulatory watch: Speedy validation sought for new cardiotoxicity testing strategy.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 655, doi. 10.1038/nrd4112

By:

Chi, Kelly Rae

Publication type:

Article

Kinase inhibitors: A molecular target for myelodysplastic syndromes.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 664, doi. 10.1038/nrd4108

By:

Tse, Man Tsuey

Publication type:

Article

Tachi Yamada.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 658, doi. 10.1038/nrd4110
Publication type:: Article

Eli Lilly wins Alzheimer's antibody patent dispute.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4122
Publication type:: Article

Heart disease: Tacrolimus shows promise in PAH models.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 666, doi. 10.1038/nrd4117

By:

Charlotte, Harrison

Publication type:

Article

Drug properties: A method to measure target engagement in cells.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 666, doi. 10.1038/nrd4118

By:

Charlotte, Harrison

Publication type:

Article

50 years of hurdles and hope in anxiolytic drug discovery.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 667, doi. 10.1038/nrd4075

By:

Griebel, Guy;
Holmes, Andrew

Publication type:

Article

Neurodegenerative disorders: Linking apolipoprotein E to LOAD.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 664, doi. 10.1038/nrd4106

By:

Crunkhorn, Sarah

Publication type:

Article

Cancer: Special delivery service.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 663, doi. 10.1038/nrd4107

By:

Flight, Monica Hoyos

Publication type:

Article

Gene therapy: Decoy viral capsids boost vector delivery.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 666, doi. 10.1038/nrd4116

By:

Charlotte, Harrison

Publication type:

Article

A comeback for anti-CD3s in type 1 diabetes?

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 653, doi. 10.1038/nrd4120
Publication type:: Article

Irreversible kinase inhibitors gain traction.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 649, doi. 10.1038/nrd4103

By:

Sanderson, Katharine

Publication type:

Article

The epigenetics pipeline.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 661, doi. 10.1038/nrd4091

By:

DeWoskin, Vivian A.;
Million, Ryan P.

Publication type:

Article

Trial watch: Clinical trial boost for lentiviral gene therapy.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 654, doi. 10.1038/nrd4111

By:

Flight, Monica Hoyos

Publication type:

Article

Appropriate evidence for adaptive marketing authorization.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 647, doi. 10.1038/nrd4114

By:

de Jong, Jean Philippe;
Grobbee, Diederick E.;
Flamion, Bruno;
Forda, Susan R.;
Leufkens, Hubert G. M.

Publication type:

Article

In this issue.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 645, doi. 10.1038/nrd4113
Publication type:: Article

Recent patents related to S1P.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 657, doi. 10.1038/nrd4125

By:

Harrison, Charlotte

Publication type:

Article

HIV: Efficacy through BibNAbs.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 666, doi. 10.1038/nrd4109

By:

Flemming, Alexandra

Publication type:

Article

First-in-class approval rate stays steady.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 653, doi. 10.1038/nrd4119
Publication type:: Article